HYRIMOZ
NDC 83457-113, adalimumab-adaz, injection, solution, from Cordavis Limited.
- Product NDC
- 83457-113
- Status
- Listed
- Labeler
- Cordavis Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761071
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83457-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADALIMUMAB80 mg/.8mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83457-113-01 | 83457011301 | 3 SYRINGE in 1 CARTON (83457-113-01) / .8 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3e303a4a-980b-4f2a-9d03-786928758637
Use it
Look up 83457-113 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83457-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83457-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.